Tamer Mohamed, founder and CEO at Aspect Biosystems added: “Our partnership with Novo Nordisk combines more than a century of ...

Ipsen has appointed Pierrick Lefranc as Executive Vice President (EVP) Technical Operations, as well as a member of its Executive Leadership Team (ELT).

Emotive has appointed Terri Cooper as Chair of the Board and Mark Swindell as Non-Executive Director.

In response to ISPOR’s recently published 2026-2027 HEOR Trends, David Miller, CEO, Genesis Research Group, suggests that ...

GlaxoSmithKline (GSK) has announced that Arexvy, its respiratory syncytial virus (RSV) vaccine, has received expanded ...

Emotive has appointed Terri Cooper as Chair of the Board and Mark Swindell as Non-Executive Director.

Sanofi and Regeneron’s Dupixent (dupilumab) has received positive final draft guidance from the National Institute for Health ...

Eisai and Biogen’s Supplemental Biologics License Application (sBLA) for Leqembi (lecanemab) subcutaneous autoinjector (SC-AI) has been accepted by the US FDA under Priority Review to treat early ...

Sanofi has announced that its amlitelimab has shown positive results in the treatment of patients 12 years and older with ...

Gilead has announced full results from its study of Trodelvy (sacituzumab govitecan) plus Keytruda (pembrolizumab) as a first ...

Alzheimer’s disease – breaking down barriers; ASH 2025 – a call to ‘Fight 4 Haematology’; Oral health – the link to ...

Skin cancer is one of the most common cancers in the US, with melanoma accounting for the majority of skin cancer deaths ...